venBio Partners
Venture capital · San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio1 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: ViceBio
17Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Parabilis Medicines | Biotech | Active | — | — |
| Acelyrin | Biotech | Acquired | — | — |
| ViceBio | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#136
Portfolio exits#103
Raises, 12 months#88
Co-investors#125
Co-investors
- Avoro Capital AdvisorsVenture capital2 shared
- Goldman Sachs AlternativesVenture capital2 shared
- Aisling CapitalVenture capital1 shared
- ARCH VentureVenture capital1 shared
- Catalio Capital ManagementVenture capital1 shared
- Cormorant Asset ManagementVenture capital1 shared
- Farallon Capital ManagementPrivate equity1 shared
- Foresite CapitalVenture capital1 shared
- Frazier Healthcare PartnersVenture capital1 shared
- LifeSci Venture PartnersVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.